EcoDrugPlus

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSSTOG00000013124
Gene Symbol: MLST8
3 Cross references
201 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSSTOG00000016054
Gene Symbol: NQO1
3 Cross references
195 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSSTOG00000008210
Gene Symbol: NOX4
3 Cross references
151 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSSTOG00000000313
Gene Symbol: NFE2L2
3 Cross references
216 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSSTOG00000020879
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSTOG00000026125
Gene Symbol: PIM1
4 Cross references
244 Possible Orthologues:

Pim-2 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSTOG00000014191
Gene Symbol: PIM2
4 Cross references
115 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSTOG00000028287
Gene Symbol: PIM3
4 Cross references
217 Possible Orthologues:

Rar Related Orphan Receptor C

Ensembl ID : ENSSTOG00000019386
Gene Symbol: RORC
4 Cross references
382 Possible Orthologues:

Rela Proto-Oncogene, Nf-Kb Subunit

Ensembl ID : ENSSTOG00000027336
Gene Symbol: RELA
3 Cross references
199 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSSTOG00000006606
Gene Symbol: ROS1
3 Cross references
124 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSTOG00000025146
Gene Symbol: RAF1
3 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).